Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post
2025-04-08 • Google News
Lyka Labs Limited (LYKALABS)
NSEINR 110.60.03%
Price Chart
Key Statistics
Market Cap
INR 3.99B
P/E Ratio
48.92
Revenue (TTM)
INR 1.38B
Volume
23.68K
52W High
INR 176.59
52W Low
INR 96.80
Dividend Yield
0.00%
Beta
0.55
Technicals
50-Day MA
114.511
200-Day MA
130.1599
52 Week High
176.59
52 Week Low
96.8
About LYKALABS
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The com.
Employees
N/A
Headquarters
Mumbai, India
CEO
Mr. Kunal Narendra Gandhi
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg